The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild ...
ImmunityBio, Inc. , a leading immunotherapy company, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public ...
Real-world treatment with liso-cel showed a broad spectrum of outcomes that were comparable to those in the pivotal TRANSFORM and PILOT trials in patients with relapsed/refractory large B-cell ...
A Novi police officer and his wife are trying to spread awareness that breast cancer can happen at any age after she got diagnosed a week before her 35th birthday.